PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Sep-2024 Agbotic Announces Strategic Licensing Transaction of AI Technology to Carbon AMS Newswire
17-Sep-2024 Angle PLC Announces Notice of Interim Results and Webcast AccessWire
17-Sep-2024 Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna Formycon AG
17-Sep-2024 Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules AccessWire
17-Sep-2024 Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules AccessWire
16-Sep-2024 Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024 AccessWire
16-Sep-2024 Nutriband Inc. Authorizes $1M Share Buyback Program AccessWire
16-Sep-2024 Hypha Labs, Inc. Uplists to the OTCQB AccessWire
16-Sep-2024 Aspen Dental: Caring for Dental Implants: Maintenance Tips and Common Issues AccessWire
16-Sep-2024 Refeyn establishes new mass photometry Scientific Advisory Board to maximize potential of transformative technology Refeyn Ltd
16-Sep-2024 AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B AAVantgarde Bio
16-Sep-2024 Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Certa Therapeutics
16-Sep-2024 Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market Richter BioLogics GmbH & Co KG
16-Sep-2024 China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis PolTREG
16-Sep-2024 Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments Transgene
16-Sep-2024 RYBREVANT®▼ (amivantamab) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer Johnson & Johnson
16-Sep-2024 Initial data from Hull collaboration project makes the case for nation-wide COPD diagnostic screening Chiesi UK & Ireland
16-Sep-2024 DistillerSR Adopts NIST AI Risk Management Framework (RMF) to Ensure the Continued Development of Trustworthy AI Solutions Newswire
16-Sep-2024 Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference AccessWire
16-Sep-2024 DistillerSR Adopts NIST AI Risk Management Framework (RMF) to Ensure the Continued Development of Trustworthy AI Solutions AccessWire